Home Featured 2

Featured 2

Featured posts

Random

TTFields in Unresectable MPM: STELLAR Results in Practice

lungcanc

Sustained Funding Vital for Smoking-Cessation Efforts

Time to End the Debate on Genomic Testing in NSCLC

Disparities in Meeting Eligibility Criteria for Lung Cancer Screening

Milestones in Lung Cancer Treatment

The Changing the Landscape of Tobacco Products: Potential Effects of ENDS...

lungcanc

Paul Bunn

The Peaks and Valleys in Lung Cancer Therapeutics Research

lungcanc

On the Backs of Specialists: LDCT Screening Has Heightened the Importance...

lungcanc

IASLC Journals Share Exciting Milestones on Metrics Journeys

lungcanc

Diagnostic Oncology: Reports from the IASLC Pathology Committee

lungcanc

Broad Molecular Testing in Lung Cancer: The Struggle to Translate Recommendations...

lungcanc

Smoking Cessation After Cancer Diagnosis: A Neglected Problem

lungcanc

Expanding Efforts Help Address Disparities in Lung Cancer Care

lungcanc

Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data

lungcanc

Déjà Vu, With a Twist: The Vaping Industry’s Approach to Youth-Oriented...

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib